Trial Details
AuthorisedBasic Information
| Clinical ID | c5073 |
|---|---|
| Identifier | EUCTR2018-004967-30-GB |
| Trial Title | IBD Reference and Biosimilar adalimumab CroSS over Study - iBaSS |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Crohn disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: ImraldiProduct Name: ImraldiPharmaceutical Form: InjectionINN or Proposed INN: adalimumabCAS Number: 331731-18-1Concentration unit: mg milligram(s)Concentration type: equalTrade Name: HumiraProduct Name: |
Participant Information
| Sponsor | University Hospital Southampton NHS Foundation Trust |
|---|---|
| City | NULL |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |